Tirzepatide 30mg
US$ 27.87
comparison of glp-1 agonists Treatment with Receptor π΄Comparison of GLP-1R Mono-Agonist vs.
Description
This creates a fundamentally different metabolic profile
PubMed, de Graaf, Chris, et al
Blood 125 , 284295 (2015)
Not as powerful as tirzepatide or retatrutide in head-to-head data
Preclinical studies in diet-induced obesity rodent models are ongoing to evaluate its efficacy, safety, and tolerability as a potential therapy for type 2 diabetes and obesity
